Alexander B. Stillebroer

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

Alexander Haese, Alexandre de la Taille, Hendrik Van Poppel et al. · European Urology · 2008 · 451 citations

Medicine, Urology, Molecular Diagnostics +11

Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram

Felix K.‐H. Chun, Alexandre de la Taille, Hendrik Van Poppel et al. · European Urology · 2009 · 178 citations

Medicine, Oncology, Urology +16

Phase 2 Study of Lutetium 177–Labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

Marye J. Boers‐Sonderen, Tim J. van Oostenbrugge, Otto C. Boerman et al. · European Urology · 2015 · 104 citations

Medicine, Oncology, Pharmacology +15

Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

Alexander B. Stillebroer, Otto C. Boerman, Ingrid M.E. Desar et al. · European Urology · 2012 · 97 citations

Medicine, Oncology, Pharmacology +12

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free‐to‐total prostate‐specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel et al. · British Journal of Urology · 2010 · 61 citations

Medicine, Oncology, Urology +17